Related references
Note: Only part of the references are listed.Effects of Conditional Central Expression of HIV-1 Tat Protein to Potentiate Cocaine-Mediated Psychostimulation and Reward Among Male Mice
Jason J. Paris et al.
NEUROPSYCHOPHARMACOLOGY (2014)
HIV-1 Tat protein variants: Critical role for the cysteine region in synaptodendritic injury
Sarah J. Bertrand et al.
EXPERIMENTAL NEUROLOGY (2013)
Phosphorylation of Dopamine Transporter Serine 7 Modulates Cocaine Analog Binding
Amy E. Moritz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Mutation of Tyrosine 470 of Human Dopamine Transporter is Critical for HIV-1 Tat-Induced Inhibition of Dopamine Transport and Transporter Conformational Transitions
Narasimha M. Midde et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Differential Regulation of Neurotoxin in HIV Clades: Role of Cocaine and Methamphetamine
Madhavan P.N. Nair et al.
CURRENT HIV RESEARCH (2012)
Neurocognitive dysfunction in the highly active antiretroviral therapy era
Nomvuyo Z. Mothobi et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2012)
MMPBSA.py: An Efficient Program for End-State Free Energy Calculations
Bill R. Miller et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2012)
HIV-1 Tat Protein Decreases Dopamine Transporter Cell Surface Expression and Vesicular Monoamine Transporter-2 Function in Rat Striatal Synaptosomes
Narasimha M. Midde et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
Eradication of HIV from the brain: reasons for pause
Avindra Nath et al.
AIDS (2011)
Current understanding of HIV-associated neurocognitive disorders pathogenesis
Patrick Gannon et al.
CURRENT OPINION IN NEUROLOGY (2011)
Cocaine and HIV-1 Interplay: Molecular Mechanisms of Action and Addiction
Shilpa Buch et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2011)
Drugs of Abuse, Dopamine, and HIV-Associated Neurocognitive Disorders/HIV-Associated Dementia
Vishnudutt Purohit et al.
MOLECULAR NEUROBIOLOGY (2011)
The Substrate-Driven Transition to an Inward-Facing Conformation in the Functional Mechanism of the Dopamine Transporter
Jufang Shan et al.
PLOS ONE (2011)
Accelerating Protein Docking in ZDOCK Using an Advanced 3D Convolution Library
Brian G. Pierce et al.
PLOS ONE (2011)
Recombinant Human Immunodeficiency Virus-1 Transactivator of Transcription1-86 Allosterically Modulates Dopamine Transporter Activity
Jun Zhu et al.
SYNAPSE (2011)
Increased dopaminergic neurotransmission in therapy-na < ve asymptomatic HIV patients is not associated with adaptive changes at the dopaminergic synapses
C. Scheller et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
Human immunodeficiency virus-1 evolutionary patterns associated with pathogenic processes in the brain
Susanna L. Lamers et al.
JOURNAL OF NEUROVIROLOGY (2010)
Single-molecule dynamics of gating in a neurotransmitter transporter homologue
Yongfang Zhao et al.
NATURE (2010)
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy CHARTER Study
R. K. Heaton et al.
NEUROLOGY (2010)
Human Immunodeficiency Virus (HIV) Infection of Human Macrophages Is Increased by Dopamine A Bridge between HIV-Associated Neurologic Disorders and Drug Abuse
Peter J. Gaskill et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains
Adarsh M. Kumar et al.
JOURNAL OF NEUROVIROLOGY (2009)
HIV-1 Tat Protein-Induced Rapid and Reversible Decrease in [H-3]Dopamine Uptake: Dissociation of [H-3]Dopamine Uptake and [H-3]2 beta-Carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) Binding in Rat Striatal Synaptosomes
Jun Zhu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
A Juxtamembrane Mutation in the N Terminus of the Dopamine Transporter Induces Preference for an Inward-Facing Conformation
Bipasha Guptaroy et al.
MOLECULAR PHARMACOLOGY (2009)
THE HUMAN IMMUNODEFICIENCY VIRUS-1-ASSOCIATED PROTEIN, TAT1-86, IMPAIRS DOPAMINE TRANSPORTERS AND INTERACTS WITH COCAINE TO REDUCE NERVE TERMINAL FUNCTION: A NO-NET-FLUX MICRODIALYSIS STUDY
M. J. Ferris et al.
NEUROSCIENCE (2009)
Role of Tat Protein in HIV Neuropathogenesis
Wenxue Li et al.
NEUROTOXICITY RESEARCH (2009)
The binding sites for cocaine and dopamine in the dopamine transporter overlap
Thijs Beuming et al.
NATURE NEUROSCIENCE (2008)
Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse
Linda Chang et al.
NEUROIMAGE (2008)
Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: Current status of dopamine system vulnerability in NeuroAIDS
Mark J. Ferris et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2008)
Intra-accumbal Tat1-72 alters acute and sensitized responses to cocaine
S. B. Harrod et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
ZRANK: Reranking protein docking predictions with an optimized energy function
Brian Pierce et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2007)
Functions of frontostriatal systems in cognition: Comparative neuropsychopharmacological studies in rats, monkeys and humans
Y. Chudasama et al.
BIOLOGICAL PSYCHOLOGY (2006)
Mechanisms of Neuroimmunity and Neurodegeneration Associated with HIV-1 Infection and AIDS
Marcus Kaul et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2006)
Estrogen attenuates gp120-and tat(1-72)-induced oxidative stress and prevents loss of dopamine transporter function
DR Wallace et al.
SYNAPSE (2006)
HIV-dementia, Tat-induced oxidative stress, and antioxidant therapeutic considerations
CB Pocernich et al.
BRAIN RESEARCH REVIEWS (2005)
Cell death in HIV dementia
MP Mattson et al.
CELL DEATH AND DIFFERENTIATION (2005)
Environmental enrichment decreases cell surface expression of the dopamine transporter in rat medial prefrontal cortex
J Zhu et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Decreased brain dopaminergic transporters in HIV-associated dementia patients
GJ Wang et al.
BRAIN (2004)
Probing dopamine transporter structure and function by Zn2+-site engineering
CJ Loland et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Generation of an activating Zn2+ switch in the dopamine transporter:: Mutation of an intracellular tyrosine constitutively alters the conformational equilibrium of the transport cycle
CJ Loland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Substantial loss of substrate by diffusion during uptake in HEK-293 cells expressing neurotransmitter transporters
P Scholze et al.
NEUROSCIENCE LETTERS (2001)
The uptake inhibitors cocaine and benztropine differentially alter the conformation of the human dopamine transporter
MEA Reith et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Pathways to neuronal injury and apoptosis in HIV-associated dementia
M Kaul et al.
NATURE (2001)
Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum
AK Bansal et al.
BRAIN RESEARCH (2000)
1H-13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein
JM Peloponese et al.
COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES (2000)
HIV dementia: the role of the basal ganglia and dopaminergic systems
JR Berger et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2000)
Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy
L Del Valle et al.
JOURNAL OF NEUROVIROLOGY (2000)
Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues
L Hudson et al.
JOURNAL OF NEUROVIROLOGY (2000)
Share Paper
